Contents x
    DMPA injectable
    • 30 Nov 2023
    • 1 Minute to read
    • Print
    • PDF
    Contents

    DMPA injectable

    • Updated on 30 Nov 2023
    • 1 Minute to read
    • Print
    • PDF
    Article summary

    • The progestogen only injectable (DMPA) is highly likely to be effective for endometrial protection with oestrogen as part of HRT; however, it cannot be recommended for this use due to a lack of data.
    • DMPA injections are safe to use alongside HRT.
    • Examples include Depo Provera (lasts 13 weeks), Sayana Press (13 weeks) and Noristerat (8 weeks).
    • Most women will be amenorrheic with their use.
    • Women should be informed that DMPA injections are associated with a small reduction in bone mineral density, but this usually recovers after discontinuation.
    • These are considered high dose progestogens. Other lower dose options might be preferable in menopausal women.
    References and Further Information:
    Was this article helpful?
    What's Next